Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
23/11/2010 | external link
Oncothyreon Reports Positive Data from Phase...
NIH scientists show how anthrax bacteria impair immune response
23/11/2010 | external link
WHAT: Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early...
New insight into dementia pathophysiology
23/11/2010 | external link
Frontotemporal lobar degeneration (FTLD) refers to a group of disorders associated with degeneration of the frontal and temporal lobes of the brain. Symptoms include dementia, aphasia, and semantic disorders. Mutation of the gene for PGRN is associated with the most common form of FTLD, which is also characterized by inclusions of TDP-43 protein in the brain. Abnormal accumulation of TDP-43 ha...
Rensselaer mechanical engineers win first place at ASME student manufacturing design competition
23/11/2010 | external link
Troy, N.Y. For the second year in a row, a pair of Rensselaer students took first place at the annual Student Manufacturing Design Competition held by the American Society of Mechanical Engineers (ASME). Mechanical engineering doctoral students Casey Hoffman and Jaron Kuppers won top honors in the national competition last month for their innovative Specialized Elastomeric Tooling (SET)...
Tecnalia investigates nanoparticles for soil remediation
23/11/2010 | external link
Tecnalia, through its Construction Unit, aims to increase the efficiency, reduce execution times and cut operational costs associated with remedial solutions for contaminated sites and for building development itself. Applications in nanotechnology appear to have no limit and currently scientific work is being undertaken which shows that the application of certain nanoparticles is highly s...
Chemicals' study pinpoints threat to workers' lungs
23/11/2010 | external link
Tiny particles used in a range of everyday products from computers to shampoo can adversely affect the lungs in very different ways, a study has shown. Research by the University of Edinburgh suggests that industrial manufacturers using nanoparticles should be aware of the risks that different types of nanoparticles pose to workers who handle them. Nanoparticles which can be 10,000 ti...
Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany
23/11/2010 | external link
Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for...
GeneLink Reports Third Quarter Results
23/11/2010 | external link
ORLANDO, Fla., Nov. 18, 2010 /- GeneLink, Inc. (OTCBB: GNLK ), a leading consumer genomics biotech company, today reported financial results for the fiscal quarter ended September 30, 2010. Highlights: Gross Profit Margin Increase of 28% GeneLink named to Deloitte's Technology Fast 500™ for the second year in a row GeneLink announces Private Label Agreement...
YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
23/11/2010 | external link
YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
Ridge Diagnostics, Inc. Presents Clinical Data on Blood Test for Depression at U.S. Psychiatric and Mental Health Congress
23/11/2010 | external link
SAN DIEGO, Nov. 18, 2010 /- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that data from a Clinical Experience Program for its first-in-class, proprietary blood test for Major Depressive Disorder (MDD) will be presented during a poster session entitled Clinician Acceptance and Utility of a Multianalyte Biomarker Panel for Major Depressive Disorder (MDD) Diagno...
Reportlinker Adds Global Bladder Cancer Therapeutics Industry
23/11/2010 | external link
NEW YORK, Nov. 18, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Bladder Cancer Therapeutics Industry http://www.reportlinker.com/p0181075/Global-Bladder-Cancer-Therapeutics-Industry.html This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate compre...
Medizone International Secures $10,000,000 Funding Commitment
23/11/2010 | external link
SAN FRANCISCO, Nov. 18, 2010 /- Medizone International, Inc. (OTC Bulletin Board: MZEI ) (OTCQB: MZEI) announced today that it has entered into a common stock purchase agreement establishing a $10,000,000 equity line with Mammoth Corporation of Lake Zurich, IL. The agreement is for a two-year term. Under the terms of the agreement, Mammoth will purchase the C...
BioSpace Highlights the Northwest's Growing Life Science Region
23/11/2010 | external link
DENVER, Nov. 18, 2010 /- BioSpace launched the 2011 BioForest™ Hotbed Campaign this morning, showcasing biotechnological, pharmaceutical and medical device companies across the United States and Canada. (Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20040907/CLTU006LOGO) The campaign promotes life science org...
Crescent Healthcare Expands East Coast Presence
23/11/2010 | external link
ANAHEIM, Calif., Nov. 18, 2010 /- Crescent Healthcare today announced a planned expansion of their east coast operations in 2011. They signed a lease to open an infusion pharmacy in Totowa, New Jersey, central to providing immune globulin therapies and services to current patients in Massachusetts, Maryland, New York, New Jersey, Pennsylvania, Connecticut, Delaware, District of Colu...
HeartWare to Present at the 22nd Annual Piper Jaffray Health Care Conference
23/11/2010 | external link
FRAMINGHAM, Mass. and SYDNEY, Nov. 18, 2010 /- HeartWare International, Inc. (Nasdaq: HTWR ) (ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the 22nd Annual Piper Jaffray...
FDA review on transgenic salmon too narrow
23/11/2010 | external link
DURHAM, N.C. -- The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to analysis by a Duke University-led team in this week's Science . The salmon, whose genome contains inserted genes from two other fish species, could become the first gen...
Doctoral candidate publishes on graphene's potential with NSF support
23/11/2010 | external link
Since graphene was first isolated in 2004 with the help of Scotch tape, researchers have excitedly turned to the material to discover its potential applications. A single layer of carbon atoms whose applications range from ultrafast electronics to biosensors to flexible displays, graphene is strong, light, transparent, and a conductor of heat and electricity. But what can we do with this new m...
Wiley-VCH launches new journal Advanced Energy Materials
23/11/2010 | external link
Wiley-VCH today announced the launch of the journal Advanced Energy Materials , a new international scientific journal dedicated to publishing high impact research in energy-related materials. "Our mission is to support the global quest for energy solutions with this dedicated new journal," says Deputy Editor of Advanced Materials, Dr. Martin Ottmar. "The Advanced journals family is the i...
Ultrathin alternative to silicon for future electronics
23/11/2010 | external link
There's good news in the search for the next generation of semiconductors. Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley, have successfully integrated ultra-thin layers of the semiconductor indium arsenide onto a silicon substrate to create a nanoscale transistor with excellent electronic...



